News Digest / Income Statements / MASIMO Reports Q2 2025 Financial Gains Amid Non-Healthcare Business Losses and Strategic Shift

MASIMO Reports Q2 2025 Financial Gains Amid Non-Healthcare Business Losses and Strategic Shift

StockInvest.us
06:09pm, Tuesday, Aug 05, 2025
Illustration by StockInvest.us

MASIMO Corporation (NASDAQ: MASI) has reported its financial results for the second quarter ended June 28, 2025, including key highlights about its ongoing business operations and financial performance.

Positive Aspects:

  • Revenue Growth: Total revenue increased to $370.9 million, a 7.9% rise compared to $343.9 million in Q2 2024.
  • Gross Profit Increase: Gross profit improved to $233.3 million (62.9% of revenue) from $207.3 million (60.3% of revenue), attributed to operational efficiencies.
  • Operating Income Rise: Operating income rose to $64.5 million from $41.9 million year-over-year.
  • Improved Net Income: Net income increased to $51.3 million (basic income per share of $0.95) from $16.0 million in the same quarter last year.

Negative Aspects:

  • Discontinued Operations: The non-healthcare business experienced a significant loss of $211.5 million for the six months ended June 28, 2025, largely due to impairment charges.
  • Increased Operating Expenses: Selling, general and administrative expenses rose to $138.9 million from $126.3 million, reflecting higher legal and professional fees.
  • Non-operating Losses: Non-operating losses were reported at $9.1 million, an improvement from the previous loss of $11.1 million, primarily driven by interest expenses.

Key Statistics:

  • Total Assets: $2,402.6 million (June 28, 2025) vs. $2,625.7 million (December 28, 2024).
  • Total Liabilities: $1,359.8 million (June 28, 2025) vs. $1,573.8 million (December 28, 2024).
  • Cash and Cash Equivalents: $149.6 million (June 28, 2025) vs. $123.6 million (December 28, 2024).
  • Debt: Total debt was $598.7 million, down from $714.3 million at the end of 2024.
  • Net Income Margin: 13.8% for the quarter ended June 28, 2025.

In terms of corporate developments, MASI is in the process of selling its non-healthcare business, anticipated to close by the end of 2025, providing a financial inflow of $350 million. This move is part of its strategic shift to focus on core healthcare operations, particularly amid recent disruptions. Additionally, the company faced a cyber incident in April 2025, which temporarily impacted operations but was promptly addressed, resulting in an expenditure of approximately $4.5 million.

Moving forward, MASIMO plans to streamline its processes and solidify its market position while remaining aware of economic trends such as inflation, part of its comprehensive outlook for sustained growth and profitability.

About The Author

StockInvest.us

StockInvest.us is a stock market research tool that provides daily stock signals and technical analysis for over 25 000 tickers on 38 exchanges. The company was founded in 2016 in Vilnius, Lithuania.

Trusted Broker
Start Your Journey With:
eToro
0% Commission Stock Trading
Follow Other Investors Strategy
Wide variety: Crypto, stocks, ETFs

Securities trading offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk.